Mode of action of a sympathomimetic amine, paramethoxyphenylethylamine (PMPEA) in the mouse CNS: Release of biogenic amines.
Paramethoxyphenylethylamine (PMPEA) is a sympathomimetic amine, like its parent compound, phenylethylamine. The intraperitoneal administration of PMPEA to mice produces a dose-dependent depletion of brain and heart norepinephrine, with significant reduction being observed one hour postinjection. At lower dosages, PMPEA produces a transitory increase in brain serotonin (5-HT) levels, with depletion observed at the higher dosage used. Thus PMPEA differs from phenylethylamine, which does not deplete 5-HT. The results are interpreted that: the behavioral and neurophysiological effects of PMPEA may be related in part to the effects of this amine on serotonergic systems as well as to its effects on monoaminergic systems.